Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - DP VII ASSOCIATES LP
Last Updated 
17-Jun-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

DP VII ASSOCIATES LP: Declared Holdings
Company/RelationshipReportedShares  Ownership
Achaogen, Inc.
Beneficial Owner (10% or more)
NasdaqGM:AKAO
(historical quotes, profile, other insiders)
17-Mar-1433,890  Direct
Clovis Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGS:CLVS
(historical quotes, profile, other insiders)
4-Jun-1344,034  Direct
Esperion Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ESPR
(historical quotes, profile, other insiders)
1-Jul-1335,253  Direct
Evoke Pharma, Inc.
Beneficial Owner (10% or more)
NasdaqCM:EVOK
(historical quotes, profile, other insiders)
30-Sep-1319,006  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
17-Mar-14 33,890AKAO Acquisition (Non Open Market)
30-Sep-13 19,006EVOK Acquisition (Non Open Market)
1-Jul-13 30,462ESPR Acquisition (Non Open Market)
1-Jul-13 4,791ESPR Purchase at $14 per share.
(Cost of $67,074)
4-Jun-13 2,779CLVS Sale at $64.58 per share.
(Proceeds of $179,467)
6-Mar-13 1,651CLVS Sale at $24.51 per share.
(Proceeds of $40,466)
5-Mar-13 2,132CLVS Sale at $24.69 per share.
(Proceeds of $52,639)
4-Mar-13 417CLVS Sale at $24.44 per share.
(Proceeds of $10,191)

 

 


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?